# HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population

> **NCT00600236** · PHASE3 · WITHDRAWN · sponsor: **Asociación para Evitar la Ceguera en México**

## Conditions studied

- Diabetes Mellitus Type 2
- Proliferative Diabetic Retinopathy

## Interventions

- **PROCEDURE:** blood sample

## Key facts

- **NCT ID:** NCT00600236
- **Lead sponsor:** Asociación para Evitar la Ceguera en México
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2004-09
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** poor accrual
- **Last updated:** 2024-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00600236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00600236, "HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00600236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
